Meetings and Events > CINRG Presentations

CINRG Presentations

Below is a listing of CINRG related presentations made at various meetings. Please contact us either by email at info@cinrgresearch.org for information about a specific presentation.

Comparison of Quantitative Strength Measures in Boys with DMD: HHM vs. CQMS

Date Presented: October 18-22, 2011

Where Presented: 16th Annual Congress of the World Muscle Society; Almancil, Algarve, Portugal

Authors: Duong, Cnaan, Hu, Leshner. Presented by Tina Duong.


Genetic modifiers of disease severity in Duchenne muscular dystrophy

Date Presented: November 2-6, 2010

Where Presented: American Society of Human Genetics Annual Conference; Washington, DC, USA

Authors: Kesari, Devaney, Gordish-Dressman, McDonald, Cooperative International Neuromuscular Research Group (CINRG), FAMuSS group, and Hoffman. Presented by Akanchha Kesari.


The Diagnostic Process in Duchenne Muscular Dystrophy Families: The CINRG Experience

Date Presented: October 14-17, 2010

Where Presented: The National Society of Genetic Counselors Annual Education Conference; Dallas, Texas, USA

Authors: Hache, Arrieta, McDonald, Henricson, Clemens. Presented by Lauren Hache.


Parent proxy-reported health-related quality of life in an observational study of boys with confirmed Duchenne muscular dystrophy using the PedsQL generic core scales

Date Presented: July 17-22, 2010

Where Presented: International Congress on Neuromuscular Diseases; Naples, Italy

Authors: Henricson, McDonald, Abresch, Han, Leshner, Cnaan, Zimmerman, Arrieta, and the CINRG Investigators. Presented by Erik Henricson.


A Cooperative International Neuromuscular Research Group (CINRG) Study of the Relationship Between Impairment, Activity Limitation, Participation and Quality of Life in Persons With Confirmed Dystrophinopathies: One Year Follow-Up of Skeletal Muscle Strength and Timed Motor Performance

Date Presented: July 17-22, 2010

Where Presented: International Congress on Neuromuscular Diseases; Naples, Italy

Authors: Henricson, McDonald, Abresch, Han, Leshner, Cnaan, Hu, Zimmerman, Duong, Arrieta, and the CINRG Investigators. Presented by Erik Henricson.


A Cooperative International Neuromuscular Research Group (CINRG) Study of the Relationship Between Impairment, Activity Limitation, Participation and Quality of Life in Persons With Confirmed Dystrophinopathies: One Year Follow-Up of Skeletal Muscle Strength and Timed Motor Performance

Date Presented: April 10-17, 2010

Where Presented: Annual Meeting of the American Academy of Neurology; Toronto, Canada

Authors: Henricson, McDonald, Abresch, Han, Leshner, Hoffman, Escolar, Cnaan, Hu, Zimmerman, Duong, Florence, Arrieta, and the CINRG Investigators. Presented by Craig McDonald.


Functional Motor Performance Characteristics of Boys with Duchenne Muscular Dystrophy by Age Groups and Steroid Use: One-Year Data from the CINRG Longitudinal Study Project

Date Presented: April 10-17, 2010

Where Presented: Annual Meeting of the American Academy of Neurology; Toronto, Canada

Authors: McDonald, Henricson, Abresch, Han, Leshner, Escolar, Hoffman, Cnaan, Arrieta, Hu, Zimmerman, Duong, Florence, and the CINRG Investigators. Presented by Craig McDonald.


The Use of Ulnar Length in Height Calculation for Boys with DMD: Results from a CINRG Natural History Study

Date Presented: November 2009

Where Presented: Treat-NMD and NIH "Bringing Down the Barriers"; Brussels, Belgium

Authors: Duong, Cnaan, Abresch, Henricson, Hu, Leshner, McDonald, and the CINRG Investigators. Presented by Florence.


Relationship between Different Timed Tests in Duchenne Muscular Dystrophy: the CINRG Experience

Date Presented: November 2009

Where Presented: Treat-NMD and NIH "Bringing Down the Barriers"; Brussels, Belgium

Authors: Cnaan, Duong, Henricson, Abresch, Leshner, McDonald, and the CINRG Investigators. Presented by Florence.


Characterization of Disease-Causing Mutations in Duchenne Muscular Dystrophy from the Cooperative International Neuromuscular Research Group

Date Presented: November 2009

Where Presented: National Society of Genetic Counselors Annual Meeting; Atlanta, GA

Authors: Hache, Feingold, Escolar, Grubs, McDonald, and Clemens. Presented by Hache.


Comparison of Disease-Causing Mutations in Duchenne Muscular Dystrophy from the Cooperative International Neuromuscular Research Group with Two Large DMD Mutation Databases

Date Presented: September 2009

Where Presented: World Muscle Society; Geneva, Switzerland

Authors: Hache, Feingold, Escolar, McDonald, and Clemens. Presented by Hache.


A Cooperative International Neuromuscular Research Group (CINRG) Study of the Relationship Between Impairment, Activity Limitation, Participation and Quality of Life in Persons with Confirmed Dystrophinopathies: Methods and Baseline Characteristics

Date Presented: April 25 - May 2, 2009

Where Presented: Annual Meeting of the American Association of Neurology; Seattle, WA

Authors: Henricson, McDonald, Abresch, Han, Leshner, Hoffman, Escolar, Cnaan, Hu, Zimmerman, Duong, Mayhew, Florence, Arrieta. Presented by Henricson.


Behavioral Outcomes of a CINRG Multi-Center, Double-Blind, Controlled Study Comparing High Weekly vs. Low Daily Dose Prednisone Therapy in Boys with Duchenne Muscular Dystrophy

Date Presented: April 25 - May 2, 2009

Where Presented: Annual Meeting of the American Association of Neurology; Seattle, WA

Authors: Fridman, Clemens, Hache, Weimer, Abdel-Hamid, Cnaan A, Hu F. Presented by Fridman.


Pulmonary Function Characteristics of 255 Boys with Becker and Duchenne Muscular Dystrophy by Age Groups, Ambulatory Status and Steroid Use: Baseline Data from the CINRG Longitudinal Study Project

Date Presented: April 25 - May 2, 2009

Where Presented: Annual Meeting of the American Association of Neurology; Seattle, WA

Authors: Abresch, McDonald, Henricson, Han, Leshner, Escolar, Hoffman, Cnaan, Arrietta, Hu, Zimmerman, Duong, Mayhew, Florence, and the CINRG Investigators. Presented by McDonald.


A Comparison of Novel High Dose Prednisone and Standard Daily Prednisone in Ambulant Boys with Duchenne Muscular Dystrophy: A CINRG Study

Date Presented: September 29 - October 2, 2008

Where Presented: World Muscle Society: Newcastle upon Tyne, United Kingdom

Authors: Leshner, Connolly, McDonald, Viswanathan, Kornberg, Bertorini, Nevo, Lotze, Ryan, Clemens, Morgenroth, Pestronk, Zimmerman, Arrieta, Henricson, Mayhew, Florence, Duong, Hu, Tesi-Rocha, Cnaan, Escolar. Presented by Clemens.


A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy

Date Presented: September 29 - October 2, 2008

Where Presented: World Muscle Society: Newcastle upon Tyne, United Kingdom

Authors: Escolar, Gorni, Tesi-Rocha, Mah, Nevo, Kornberg, Kolski, Bertorini, Connolly, Kuntz, Zimmerman, Morgenroth, Arrieta, Mayhew, Florence, Nei, Hu, Henricson, Leshner, and Dubrovsky. Presented by Leshner.


CINRG Randomized, Double-Blind, Controlled Study To Compare Efficacy and Tolerability of Standard Daily Prednisone Regime with a Novel Intermittent Pulse Dose Regime in Ambulant Boys with Duchenne Muscular Dystrophy

Date Presented: April 12-19, 2008

Where Presented: American Academy of Neurology Annual Meeting; Chicago, IL

Authors: Escolar, McDonald, Viswanathan, Kornberg, Bertorini, Nevo, Lotze, Ryan, Clemens, Leshner, Pestronk, Morgenroth, Zimmerman, Arrieta, Henricson, Mayhew, Florence, Duong, Nei, Hu, Tesi-Rocha, Connolly. Presented by Escolar.


Pentoxifylline Treatment Fails to Rescue Muscle Strength and Function Deterioration in Prednisone Treated Duchenne Muscular Dystrophy

Date Presented: April 12-19, 2008

Where Presented: American Academy of Neurology Annual Meeting; Chicago, IL

Authors: Escolar, Gorni, Tesi-Rocha, Mah, Nevo, Kornberg, Kolski, Bertorini, Connolly, Kuntz, Clemens, Zimmerman, Morgenroth, Arrieta, Mayhew, Florence, Nei, Hu, Henricson, Leshner, Dubrovsky. Presented by Escolar.


Immediate Release Oral Pentoxifylline is Poorly Tolerated in Duchenne Muscular Dystrophy Boys

Date Presented: April 12-19, 2008 and October 17-20, 2007

Where Presented: American Academy of Neurology Annual Meeting; Chicago, IL and World Muscle Society; Sicily, Italy

Authors: Tesi-Rocha, Kuntz, Clemens, Iannaccone, Pestronk, Zimmerman, Henricson, Arrieta, Nei, Markle, Connolly, Escolar. Presented by Escolar.


Health-Related Quality of Life in Disabled Teens: Comparison of PedsQL in Duchenne Muscular Dystrophy, Spinal Cord Dysfunction, and Able-Bodied Controls

Date Presented: October 11, 2007

Where Presented: Annual Meeting of the American Academy of Cerebral Palsy and Developmental Medicine.

Authors: McDonald, Escolar, Henricson, Abresch and the CINRG Investigators. Presented by McDonald.


CINRG Open Label Pilot Clinical Trial of Coenzyme Q10 in Steroid Treated Duchenne Muscular Dystrophy

Date Presented: April 1-8, 2006

Where Presented: American Academy of Neurology Annual Meeting; San Diego, CA

Authors: Escolar, Henricson, Tesi-Rocha, McCarter, Gordish. Presented by Escolar.


A CINRG Pilot Trial of Oxatomide in Steroid-Naïve Duchenne Muscular Dystrophy

Date Presented: April 1-8, 2006

Where Presented: American Academy of Neurology Annual Meeting; San Diego, CA

Authors: Buyse, Goemans, Henricson, Jara, van den Hauwe, Leshner, Florence, Mayhew, Escolar. Presented by Buyse.


 

Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.